🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
Using an established model of human typhoid infection, whereby healthy adul...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2015-09
Trial ID
NCT02324751
Treatments Being Tested
The purpose of this study in healthy toddlers who have not previously been ...
Status
Completed
Location
Werderstrasse 3
Start Date
2008-03
Trial ID
NCT00617760
The purpose of the study is to evaluate the immune response of toddlers, to...
Status
Completed
Location
Universidad Rey Juan Carlos I
Start Date
2007-01
Trial ID
NCT00392808
Treatments Being Tested
Persistence of Immune response after vaccination with MCC...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Start Date
2004-10
Trial ID
NCT00310687
Treatments Being Tested
Primary Series Primary objectives * To demonstrate that the concomitant ad...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site 003
Start Date
2013-04
Trial ID
NCT01839175
Treatments Being Tested
The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-24
Trial ID
NCT00871338
Treatments Being Tested
The purpose of the study is to evaluate the immunogenicity, safety and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-22
Trial ID
NCT00136604
Treatments Being Tested
The purpose for this study is to demonstrate the safety and immunogenicity ...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01359449